Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology products and services for research and development in the medical, nutrition, cosmetics and energy industries. The AMSBIO range includes specialist antibodies, peptides and recombinant proteins.
In addition the company is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as experts in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance screening outcomes and eventual prognosis.
With a range of molecular detection and manipulation reagents, and a significant Biorepository the company also provides tissue DNA, RNA, protein, microarray and gene editing products. Key research areas for these include: Oncology, Regenerative Medicine, Drug Toxicity Analysis, DNA Damage Screening, Glycomics and Stem Cell Biology.